Universitetska Mnogoprofilna Bolnitsa Za Aktivno Lechenie Medika Ruse OOD

Ruse 9 trials 3 recruiting

9 Registered trials

3 Currently recruiting

Organisation

Universitetska Mnogoprofilna Bolnitsa Za Aktivno Lechenie Medika Ruse OOD

Location

Ruse, Bulgaria

Identifier

ORG-100042324

Address

Ulitsa Riga 35, 7013, Bulgaria

Departments

Department of Dialysis Treatment
Department of internal diseases
Department of Neurology Diseases
Gastroenterology
Internal Diseases Department

Clinical trials at this site (9)

Search interface

A study to test if tenecteplase helps people to recover from an acute stroke when given more than 4.5 hours after the person was last seen w… Pending

2025-522542-40-00 Acute Ischemic Stroke 5
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients with P… Recruiting

2024-514617-35-00 Progressive forms of Multiple Sclerosis 4 2021-12-20
Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis Recruiting

2023-503634-50-01 Anemia in patients with chronic kidney disease on dialy 5 2025-07-22
A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin on clinical outcomes alone and how safe it is in adu… Recruiting

2023-506460-14-00 Chronic kidney disease (CKD) and hypertension. 5 2025-05-07
REDEFINE 3: A research study to see the effects of CagriSema in people living with diseases in the heart and blood vessels Ended

2023-506924-94-00 Cardiovascular disease 5 2023-02-28
A Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adu… Ended

2024-514618-11-00 Relapsing Multiple Sclerosis 5 2022-03-01
A study to compare the effect of AVT16 and Entyvio® in subjects with moderate to severe active ulcerative colitis. Ended

2023-507705-34-00 Moderate to Severe Active Ulcerative Colitis 5 2025-08-29
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202 in Patients with Mild-to-Moderate Ulcerative Colitis Ended

2024-512558-40-00 Mild-to-moderate ulcerative colitis 4 2023-05-11
PROLONGSTEM is a long term follow-up study of all the patients who have received at least one infusion of HepaStem Ended

2022-500251-22-00 This study will include all patients having received at 4 2018-04-12